Ancora Advisors LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 213 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ancora Advisors LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,008
-95.6%
14
-90.7%
0.00%
-100.0%
Q1 2021$23,000
+53.3%
1500.0%0.00%
Q4 2020$15,000
+7.1%
1500.0%0.00%
-100.0%
Q3 2020$14,000
-17.6%
1500.0%0.00%0.0%
Q2 2020$17,000
+54.5%
1500.0%0.00%0.0%
Q1 2020$11,000
-31.2%
1500.0%0.00%0.0%
Q4 2019$16,000
-61.0%
1500.0%0.00%
-50.0%
Q3 2018$41,000
+173.3%
1500.0%0.00%
+100.0%
Q4 2016$15,0001500.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders